本页面由Tiger Trade Technology Pte. Ltd.提供服务

Janux Therapeutics, Inc.

18.15
-0.2400-1.31%
盘后:18.150.00000.00%19:30 EDT
成交量:80.30万
成交额:1,459.59万
市值:11.10亿
市盈率:-11.05
高:18.61
开:18.29
低:17.96
收:18.39
52周最高:35.34
52周最低:12.12
股本:6,113.68万
流通股本:4,252.58万
量比:0.77
换手率:1.89%
股息:- -
股息率:- -
每股收益(TTM):-1.6429
每股收益(LYR):-1.8336
净资产收益率:-10.70%
总资产收益率:-8.80%
市净率:1.20
市盈率(LYR):-9.90

数据加载中...

2024/09/27

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/09/27

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/09/27

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/09/27

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/09/27

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/09/27

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/09/26

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/09/26

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/09/26

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/09/16

超过5%披露

Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
2024/09/16

超过5%披露

Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
2024/09/13

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/09/12

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/09/12

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/09/12

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/09/12

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/09/10

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/09/10

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/09/10

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/09/10

关联方拟减持公告

Form 144 - Report of proposed sale of securities